CryoPort, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by CryoPort, Inc. on February 20, 2009. The report addresses significant changes in the company's executive leadership and board composition effective immediately on the filing date.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and personnel changes rather than financial performance.
Material Changes
- Appointment of CEO and President: The Board of Directors elected Larry G. Stambaugh to serve as President and Chief Executive Officer, effective immediately.
- Board Role: Mr. Stambaugh will maintain his position as Chairman of the Board.
- Transition of Prior CEO: Peter Berry, the former President and CEO, has transitioned to an advisory role as a consultant to Mr. Stambaugh while retaining his seat on the Board of Directors.
Management Commentary and Outlook
Mr. Stambaugh brings over 30 years of experience in building global businesses, with a specific background in life sciences and clean tech. His expertise includes strategic direction, turnarounds, and board governance, along with established relationships with Contract Research Organizations (CROs), biotech, and pharmaceutical companies. Prior to this appointment, he served as a Principal at Apercu Consulting.
Compensation: The compensation package for Mr. Stambaugh is currently under review by the Compensation and Governance Committee and will be filed for public view upon finalization.
Investor Verification Checklist
- Verify the finalized compensation package for Larry G. Stambaugh once filed by the Compensation and Governance Committee.
- Confirm the specific terms of Peter Berry's advisory and consulting agreement.
- Review subsequent filings for any strategic shifts in business direction attributed to the new leadership.